Biotechnology
Company Overview of 3SBio Inc.
Company Overview
No. 3 A1, Road 10
Shenyang Economy & Technology Development Zone
Shenyang, 110027
China
Founded in 1993
891 Employees
Key Executives for 3SBio Inc.
3SBio Inc. Key Developments
3SBio Inc. will be removed from NASDAQ Composite Index.
3SBio Inc. Presents at Fifth Annual ChinaBio(R) Partnering Forum 2013, May-29-2013 . Venue: Shangri-La Hotel, 29 Zizhuyuan Road, Beijing 100089, China.
3SBio Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2012. For the quarter the company reported, total net revenues were RMB 163,950,000 against RMB 139,882,000 for the same period a year ago. This increase was largely due to continued strong sales of EPIAO and TPIAO which grew by 6.9% and 30.8%, respectively, over the same period in 2011. Operating income was RMB 11,498,000 against RMB 26,085,000 for the same period a year ago. Income before income tax expense was RMB 22,237,000 against RMB 28,396,000 for the same period a year ago. Net income attributable to 3SBio Inc. was RMB 17,107,000 or RMB 0.11 diluted per share against RMB 22,342,000 or RMB 0.14 diluted per share for the same period a year ago. Net income attributable to 3SBio Inc. diluted per ADS was RMB 0.75 against RMB 0.99 for the same period a year ago. For the year the company reported, total net revenues of RMB 669,948,000 against RMB 541,614,000 for the same period a year ago. The increase was largely due to continued strong sales of EPIAO and TPIAO, underpinned by continued strong demand in the oncology and nephrology markets. Operating income was RMB 128,821,000 against RMB 121,646,000 for the same period a year ago. Income before income tax expense was RMB 132,453,000 against RMB 136,370,000 for the same period a year ago. Net income attributable to 3SBio Inc. was RMB 102,354,000 or RMB 0.64 diluted per share against RMB 108,573,000 or RMB 0.69 diluted per share for the same period a year ago. Net income attributable to 3SBio Inc. diluted per ADS was RMB 4.51 against RMB 4.84 for the same period a year ago. Non-GAAP net income attributable to 3SBio Inc. was RMB 122,781,000 against RMB 108,573,000 for the same period a year ago. Non-GAAP net income attributable to 3SBio Inc. per ADS on a fully-diluted basis increased to RMB 5.41 against RMB 4.84 for the same period a year ago.
Similar Private Companies By Industry
Recent Private Companies Transactions
| Type Date |
Target |
|
Merger/Acquisition
September 12, 2012 |
-- |
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Buffalo, NY | Major International BankPosted: Jun 19
- Illinois | Miller AgPosted: Jun 14
- Tarrytown, NY | Bridgeview ITPosted: Jun 16
Sponsored Financial Commentaries
Sponsored Links
To contact 3SBio Inc., please visit www.3sbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
